Abstract
The burgeoning liver disease at the interface of metabolic syndrome and type 2 diabetes: Nonalcoholic fatty liver disease (NAFLD)
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have